British National Formulary Summary of Product Characteristics Information
(if you search on a drug name in the search box above, clicking the BNF/SPC icons under the drug entry will take you directly to relevant web page)
British National Formulary for Children Guys/St Thomas/Kings/Lewisham Paediatric Formulary Another useful paediatric guide to the administration of medicines in children and young people can be accessed here: http://www.knowledge.scot.nhs.uk/child-services/communities-of-practice/neonatal-managed-clinical-networks/west-of-scotland/neonatal-drug-formulary-(wos).aspx
HIGH COST DRUGS MANUAL - Kent and Medway health economy national tariff excluded drugs
The purpose of this manual is to describe the process for funding National Tariff Excluded Drugs (NTEs) these are the high cost drugs or devices excluded from the National Tariff payment system (National Tariff), previously known as National Tariff Exclusions (National Tariff). The May 2019 update is in a different format and has been amended based on feedback from users.
Drugs are only commissioned for those indications listed under the individual drug and with regard to locally commissioned (CCG) drugs may not be commissioned across every CCG. Information on whether a CCG has commissioned a drug can be found in the “Commissioned By” box. Invoices will be refused for indications not listed within this manual or for patients in a CCG where the drug is not commissioned.
Please see thee file below to access the recent and archived copies of Medicines Wise, the quarterly bulletin pact with information from learning incidents.
SACT pathways can be viewed using the following link:
The Critical Medicines List is now available. Please use the following link:
Obtaining Medication out of Hours
Any medication not available out of hours should be located using the drug stock file on the Intranet at ekhuft.nhs.uk/staff/clinical/antidote-drug-stock-lists/ If a medicine cannot be obtained the on-call pharmacist must be contatced for advice
TOP TWENTY MOST USED DRUGS - ADMINISTRATION ADVICE ON PATIENTS WITH SWALLOWING DIFFICULTIES OR ENTERAL FEEDING TUBES
The list below provides information relevant to alternative administration in patients with swallowing difficulties and enteral tubes in situ. The information provided is applicable to both routes unless otherwise stated.
If SIP feeds are to be continued by the GP there will be a message from the dieticians on the EDN under the dietetic summary section.
To access the Kent & Medway Catheter and Accessories First choice list please use link below
[ Kent & Medway Catheter and Accessories first choiice list ]
ABOUT THE FORMULARY
The formulary is maintained by the Medicines Information team. Contact Medicines Information for any formulary or medicine queries by email ekh-tr.MedicinesInformation@nhs.net or telephone 723-6001 (internal) or 01233 616001 (external).
This web formulary is continuously updated. There is more information about our formulary here. Within the Trust more medicines information is found on the Drugs & Therapeutic pages and clinical practice is supported by policies and guidelines on Sharepoint as well as the information on Trustnet. We are constantly mitigating medication shortages and update formulary appropriately.
A joint formulary is being developed across East Kent and this document outlines the process for requesting the inclusion of new products onto the formulary and amendments in use for current products. If the product is going to be hospital use only the request is made to the EKHUFT Drug and Therapeutics Committee (DTC); which is held on the fourth Wednesday of every second month at Buckland Hospital.If the product is going to be used across the health economy the request is made to the East Kent Prescribing Group (EKPG) which is held every third Wednesday of the month at the South Kent Coast CCG offices.In order to maximise the efficiency of the approach to assessing the suitability of products and to ensure a safe and straightforward implementation if approved; there is a substantial amount of work that needs to be done prior to any request being submitted, especially if the product is to be used across the Health Economy. The timeline from identifying a product for inclusion to it being approved for use is likely to be from 2 to 6 months, and possibly more if there are factors such as NICE decisions and the development of shared care guidelines to include Please note that the deadline for submissions to an EKPG meeting is usually the first working day of the month it is held in.
Only utilise the previous drug request form if the medication will be used within the trust at trust expense on a one off fashion
TRAFFIC LIGHT POSTER
The Traffic light poster is available at the following link
http://www.ekhuftformulary.nhs.uk/docs/prescribing%20antimicrobials%20in%20renal%20transplant%20patients.pdfe at the
MEDUSA CONTINGENCY PLANS
It has been noted that several instances have occurred where Medusa has not been available. The Trust has therefore put a contingency plan into place so that alternative rsources can be used. Please click on link below.
QUICK LINKS TO TRUST MEDICINES RELATED GUIDELINES & e-LEARNING